These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Epidemiology and prevention in dialysis]. Cherubini C; Barbera G; Petrosillo N; Di Giulio S G Ital Nefrol; 2003; 20 Suppl 22():S38-42. PubMed ID: 12851920 [TBL] [Abstract][Full Text] [Related]
6. [Almost thousand patients with nosocomial hepatitis C compensated ex gratia]. Lidman K; Ohman S Lakartidningen; 2007 Feb 28-Mar 6; 104(9):666-9. PubMed ID: 17393861 [No Abstract] [Full Text] [Related]
7. Preventing infections in hemodialysis fistula and graft vascular accesses. Deaver K Nephrol Nurs J; 2010; 37(5):503-5; quiz 506. PubMed ID: 20973304 [TBL] [Abstract][Full Text] [Related]
8. A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients. Taylor C; Cahill J; Gerrish M; Little J J Ren Care; 2008 Sep; 34(3):116-20. PubMed ID: 18786077 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(8):189-94. PubMed ID: 19265779 [TBL] [Abstract][Full Text] [Related]
10. Open for business. Proactive approach helps maintain good vascular access for dialysis patients and reduces the cost of care for providers. Becker C Mod Healthc; 2004 Feb; 34(6):28-9. PubMed ID: 14983789 [No Abstract] [Full Text] [Related]
11. A prospective study on incidence of bacterial infections in portuguese dialysis units. Ponce P; Cruz J; Ferreira A; Oliveira C; Vinhas J; Silva G; Pina E Nephron Clin Pract; 2007; 107(4):c133-8. PubMed ID: 17957124 [TBL] [Abstract][Full Text] [Related]
12. [Vascular access for haemodialysis]. Bourquelot P Nephrol Ther; 2009 Jun; 5(3):239-48. PubMed ID: 19328057 [TBL] [Abstract][Full Text] [Related]
13. Application of the forensic Luminol for blood in infection control. Bergervoet PW; van Riessen N; Sebens FW; van der Zwet WC J Hosp Infect; 2008 Apr; 68(4):329-33. PubMed ID: 18346814 [TBL] [Abstract][Full Text] [Related]
14. Predictors of hemodialysis central venous catheter exit-site infections. Harwood L; Wilson B; Thompson B; Brown E; Young D CANNT J; 2008; 18(2):26-35. PubMed ID: 18669009 [TBL] [Abstract][Full Text] [Related]
15. Blood borne virus-innovative approach to evaluate, prevent cross-transmission in dialysis units. Chow J; Miguel SS J Ren Care; 2008 Dec; 34(4):203-6. PubMed ID: 19090899 [TBL] [Abstract][Full Text] [Related]
17. IV 3000 dressing on Permcath exit sites. Latta C; Grant C EDTNA ERCA J; 1996; 22(1):7-8. PubMed ID: 10723301 [TBL] [Abstract][Full Text] [Related]
18. [Surveillance for bacteremia related to vascular access in hemodialysis]. Ferrero S; Saltarelli M; Quori A; Campobasso M; Argentero PA G Ital Nefrol; 2008; 25(3):347-53. PubMed ID: 18473306 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Rahnavardi M; Hosseini Moghaddam SM; Alavian SM Am J Nephrol; 2008; 28(4):628-40. PubMed ID: 18285684 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus reactivation in a large haemodialysis unit: virological and infection control issues. Bhattacharya S; Ijaz S; Ratnaraja N; Smith S; Osman H; Boxall E J Clin Virol; 2009 Sep; 46(1):101-3. PubMed ID: 19560397 [No Abstract] [Full Text] [Related] [Next] [New Search]